# Anemia in Patients With a Non-Myeloid Malignancy

> **NCT00038064** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 707 (actual)

## Conditions studied

- Neoplasms
- Anemia

## Interventions

- **DRUG:** Darbepoetin alfa
- **DRUG:** rHuEPO

## Key facts

- **NCT ID:** NCT00038064
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2003-10
- **Final completion:** 2004-04
- **Target enrollment:** 707 (ACTUAL)
- **Last updated:** 2008-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00038064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00038064, "Anemia in Patients With a Non-Myeloid Malignancy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00038064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*